DXB vs RCE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

RCE

RECCE LTD FPO [RCE]

40LOW

Score Breakdown

DXB RCE
Technical
45
54
Catalyst
48
62
Sentiment
50
50
Fundamental
82
23
Momentum
36
50
Risk Gate
50
45

Key Metrics

DXB Metric RCE
$141.1MMarket Cap$113.8M
3.2MAvg Volume (20d)323K
N/AShort InterestN/A
$0.66552-Week High$0.730
$0.15852-Week Low$0.310
+2.1%Daily Change-2.6%
$0.240Entry Price$0.380
-594.5%ROEN/A
-219.9%Profit MarginN/A

Active Signals

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

RCE Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting near support — this level has held before and could attract buyers again
●Lagging the Small Ords index — relative strength of 0.80, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.1 quarters)
●Very high P/S ratio (116.8x)
●Revenue in sharp decline (-94%)

Ask Scout AI to compare DXB and RCE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → RCE Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).